Lobectomy <i>vs.</i> bisegmentectomy for lung cancer in the left upper lobe: a retrospective comparative cohort study.

ABSTRACT:

Background

Lobectomy has been established as the standard treatment for resectable non-small cell lung cancer (NSCLC) since the publication of a randomized prospective clinical trial conducted by the Lung Cancer Study Group (LCSG) in the 1990s. However, this study possesses certain drawbacks from a contemporary standpoint. Over the past decades, further studies have been conducted to comprehensively outline appropriate surgical procedures for NSCLC. Segmentectomy is considered a potential alternative for predominant ground-glass opacities (GGOs) or tumors smaller than 2 cm. However, there is limited research regarding their relative benefits. We compared oncological outcomes of patients undergoing left upper lobectomy and a "multi-segmentectomy" [trisegmentectomy (S₁₊₂ +

SUBMITTER: Liu H 

PROVIDER: S-EPMC11833576 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature